Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 107,735 | 110,948 | 112,561 | 112,331 | 112,302 |
| Depreciation Amortization | 37,226 | 19,175 | 12,321 | 12,467 | 8,700 |
| Income taxes - deferred | 1,304 | -2,853 | -2,534 | -7,363 | 3,194 |
| Accounts receivable | -11,747 | 1,145 | -2,334 | -2,096 | -3,624 |
| Accounts payable and accrued liabilities | 2,154 | 1,368 | 243 | 1,581 | -591 |
| Other Working Capital | -11,367 | -1,841 | -5,269 | -3,939 | -279 |
| Other Operating Activity | 14,054 | 8,820 | 8,574 | 13,765 | 7,492 |
| Operating Cash Flow | $139,359 | $136,762 | $123,562 | $126,746 | $127,194 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,466 | 182,664 | -9,102 | -15,285 | 22,154 |
| PPE Investments | -19,905 | -13,821 | -22,454 | -6,017 | -3,630 |
| Net Acquisitions | -420,102 | -109,180 | N/A | N/A | -131,766 |
| Purchase Of Investment | N/A | -10,000 | 0 | N/A | N/A |
| Other Investing Activity | 49 | 25 | 352 | -366 | -943 |
| Investing Cash Flow | $-426,492 | $49,688 | $-31,204 | $-21,668 | $-114,185 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 163,000 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 9,731 | 8,326 | 1,105 | 847 | 4,790 |
| Common Stock Repurchased | N/A | N/A | -2,394 | -24,505 | -2,234 |
| Dividend Paid | -47,107 | -45,394 | -43,463 | -41,018 | -39,691 |
| Other Financing Activity | -94,349 | 262 | 75 | 51 | 847 |
| Financing Cash Flow | $31,275 | $-36,806 | $-44,677 | $-64,625 | $-36,288 |
| Exchange Rate Effect | -8,178 | 5,138 | -570 | -1,391 | 6,753 |
| Beginning Cash Position | 318,568 | 163,786 | 116,675 | 77,613 | 94,139 |
| End Cash Position | 54,532 | 318,568 | 163,786 | 116,675 | 77,613 |
| Net Cash Flow | $-264,036 | $154,782 | $47,111 | $39,062 | $-16,526 |
| Free Cash Flow | |||||
| Operating Cash Flow | 139,359 | 136,762 | 123,562 | 126,746 | 127,194 |
| Capital Expenditure | -19,905 | -13,821 | -22,454 | -6,017 | -3,630 |
| Free Cash Flow | 119,454 | 122,941 | 101,108 | 120,729 | 123,564 |